Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability
Ge Zhang(Hong Kong Baptist University), Junnan Tang(University of North Carolina at Chapel Hill), Yongzheng Lu(First Affiliated Hospital of Zhengzhou University), Zhenpeng Qin(The University of Texas at Dallas), Laiyi Tang(First Affiliated Hospital of Zhengzhou University), Zeyu Wang(Anhui University), Li Zhang(China Tobacco), Xiaofang Wang(First Affiliated Hospital of Zhengzhou University), Yanyan Xu(First Affiliated Hospital of Zhengzhou University), Shuai Xu(Xihua University), Xiaolin Cui(Chinese University of Hong Kong, Shenzhen), Jinying Zhang(First Affiliated Hospital of Zhengzhou University), Gangqiong Liu(First Affiliated Hospital of Zhengzhou University)
Cited by 19
Related Papers
Natural selection on <i>EPAS1</i> ( <i>HIF2α</i> ) associated with low hemoglobin concentration in Tibetan highlanders
|Proceedings of the National Academy of Sciences|2010|854
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Camelid genomes reveal evolution and adaptation to desert environments
|Nature Communications|2014|317
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
|Journal of Hematology & Oncology|2022|273